CD274 (PD-L1) and PDCD1LG2 (PD-L2) are involved in immunosuppression by tumor cells to evade cytotoxic T cell mediated killing and are associated predominantly with the EBV+ sub-type (77) in a STAT1 driven manner as discussed later in this review (153). The gene discussed is CD274; the disease is neoplasm.